CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −250 | $56.24 | $14K | 55,988 |
| 2024-12-11 | Davis Krista SVP, CHIEF HR OFFICER | Sale 10b5-1 | −1,000 | $60.00 | $60K | 49,059 |
| 2024-11-26 | Lalwani Nikhil PRESIDENT & CEO | Option exercise | +30,000 | $29.00 | $870K | 403,859 |
| 2024-11-26 | Lalwani Nikhil PRESIDENT & CEO | Sale | −30,000 | $57.95 | $1.7M | 373,859 |
| 2024-11-26 | Lalwani Nikhil PRESIDENT & CEO | Sale | −3,481 | $58.30 | $203K | 370,378 |
| 2024-11-26 | Lalwani Nikhil PRESIDENT & CEO | Option exercise · Stock Option (right to buy) | −30,000 | $29.00 | $870K | 138,027 |
| 2024-11-15 | Mutz Christopher HEAD OF RARE DISEASE | Sale | −6,500 | $57.70 | $375K | 76,777 |
| 2024-11-15 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Shares withheld for taxes | −867 | $56.58 | $49K | 33,169 |
| 2024-11-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −250 | $61.36 | $15K | 56,238 |
| 2024-10-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −250 | $57.19 | $14K | 56,488 |
| 2024-09-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −250 | $56.82 | $14K | 56,738 |
| 2024-09-12 | Davis Krista SVP, CHIEF HR OFFICER | Shares withheld for taxes | −1,486 | $56.15 | $83K | 50,059 |
| 2024-09-08 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −3,646 | $60.51 | $221K | 373,859 |
| 2024-08-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −250 | $59.62 | $15K | 56,988 |
| 2024-07-18 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes | −1,743 | $61.35 | $107K | 57,238 |
| 2024-07-18 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale 10b5-1 | −2,743 | $62.00 | $170K | 632,620 |
| 2024-07-17 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale 10b5-1 | −14,257 | $63.16 | $900K | 635,363 |
| 2024-07-16 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale 10b5-1 | −22,000 | $64.27 | $1.4M | 649,620 |
| 2024-07-15 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale 10b5-1 | −11,000 | $63.38 | $697K | 671,620 |
| 2024-07-12 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −250 | $64.91 | $16K | 58,981 |
Page 11 of 23 · 442 trades